Latest News for: fas ligand

Edit

Eat Mangoes for Gut Health—the fruit protects gastrointestinal disorders, says UoH study

The Siasat Daily 03 May 2024
The study also demonstrated anticancer effects of mangiferin on colon cancer cell line, Caco-2 by increasing the expression of pro-apoptotic markers (Fas ligand, Fas receptor, FADD, caspase-8, and ...
Edit

Coya Therapeutics Licenses Exclusive Worldwide rights to Exosome Engineering Technology (EET) from Carnegie Mellon University (CMU)

The Galveston Daily News 22 Sep 2023
HOUSTON--(BUSINESS WIRE)--Sep 22, 2023-- ... (Nasdaq ... Previously, using the same technology, CMU demonstrated applications in Oncology by engineering mesenchymal derived exosomes with an immunomodulatory apoptotic inducing protein, Fas Ligand (FAS-L) ... PUB.
Edit

Coya Therapeutics Successfully Engineers Regulatory T Cell (Treg) Derived Exosomes with CTLA-4 Protein to Selectively ...

The Eagle-Tribune 07 Sep 2023
HOUSTON--(BUSINESS WIRE)--Sep 7, 2023-- ... (NASDAQ ... Previously, using the same technology, CMU demonstrated applications in Oncology by engineering mesenchymal derived exosomes with an immunomodulatory apoptotic inducing protein, Fas Ligand (FAS-L) ... Dr ... .
Edit

Coya Therapeutics Successfully Engineers Regulatory T Cell (Treg) Derived Exosomes with CTLA-4 Protein to Selectively Target Immune Cells with Potential to Deliver Targeted Therapies Across Multiple Diseases

Pharmiweb 07 Sep 2023
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc ... Previously, using the same technology, CMU demonstrated applications in Oncology by engineering mesenchymal derived exosomes with an immunomodulatory apoptotic inducing protein, Fas Ligand (FAS-L) ... Dr ... .
Edit

Autolus Therapeutics Reports Second Quarter 2023 Financial Results and Operational Progress

Eagle-Tribune 03 Aug 2023
Scientific Publications.Publication of a paper in Molecular Therapy Nucleic Acids, titled ‘Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T-cell efficacy’.
Edit

How to activate the "first responders" of the immune system - NK cells

Pharmiweb 28 Jun 2023
In contrast, the absence of inhibitory receptor ligands and/or ... IL-18, in combination with IL-12, induces the expression of FAS ligand (FASL) in NK cells and enhances the production of IFNγ and TNF[4].
Edit

Autolus Therapeutics Reports First Quarter 2023 Financial Results and Operational Progress

Messenger-Inquirer 04 May 2023
In April 2023 Autolus announced the publication of a paper in Molecular Therapy Nucleic Acids, ‘Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T-cell efficacy.
Edit

Autolus Therapeutics Announces Publication in Molecular Therapy Nucleic Acids

Enid News & Eagle 26 Apr 2023
One such inhibitory factor is Fas ligand (FasL), which binds to the Fas receptor (CD95) on the surface of an activated T cell and triggers the CAR T cell to die by apoptosis ... Novel Fas-TNFR chimeras ...
Edit

Flawed abstract lacks mRNA heart risk evidence

The Capital Journal 20 Dec 2021
... by measuring nine protein biomarkers – hepatocyte growth factor, eotaxin, monocyte-specific chemokine 3, cutaneous T-cell-attracting chemokine, interleukin 16, Fas ligand, soluble Fas, HDL and HbA1c.
Edit

No Credible Evidence COVID-19 mRNA Vaccines ‘Dramatically Increase’ Heart Attack Risk, Contrary to Flawed Abstract

The Washington Informer 16 Dec 2021
SciCheck Digest. The COVID-19 vaccines administered in the U.S ... Full Story ... 8 ... 13 ... Steven R ... hepatocyte growth factor, eotaxin, monocyte-specific chemokine 3, cutaneous T-cell-attracting chemokine, interleukin 16, Fas ligand, soluble Fas, HDL, and HbA1c ... .
  • 1

Article Search

tools

Most Viewed

×
×
×
×